Clinical Trial Update: Abraxane in Treatment of Metastatic Breast Cancer

View source ↗

Summary

The update notes that the Abraxane trial for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: Celgene | Conditions: Metastatic Breast Cancer | Status: COMPLETED